Epic Sciences

Epic Sciences is a company founded in 2008, offering medical diagnostics characterizing circulating tumor cells.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Epic Sciences is a company founded in 2008, offering medical diagnostics characterizing circulating tumor cells. Its technology is licensed from Scripps Research Institute, based on inventions made by Peter Kuhn's lab at Scripps.[1][2]

Initially, Epic offered analysis services to companies developing drugs.

Methods

edit edit source

The company's approach involves getting a blood sample, removing red blood cells, putting the remaining cells on a microscope slide, staining the cells with antibodies for a few cancer markers, imaging the slide, then using proprietary image analysis software that counts the stained cells and analyzes the cells based on morphophology and other factors; as of 2014 it took the software around two and a half hours to analyze a single slide; around 12 slides are generated from a standard 7.5 mL blood sample.[3]

As of 2014 it was offering its analysis services to drug companies as a way to measure outcomes in clinical trials.[4]

Organization

edit edit source

David Nelson was the first President and CEO. In 2012 Epic raised $13M in 2012 from Domain Associates, Roche Venture Fund and Pfizer Venture Investments.[1]

By 2014 Murali Prahalad became the president and CEO, and in July of that year the company raised an additional $30M.[5] In April 2017, Epic raised another $40 million and as of that date had raise a total of $85.5 million.[6]

References

edit edit source
  1. ^ a b Fikes, Bradley J. (November 13, 2012). "Epic Sciences raises $13 million". San Diego Union Tribune. Wikipedia revision 1367626331, retrieved 2026-11-19
  2. ^ Bigelow, Bruce (16 February 2012). "Xconomist of the Week: Peter Kuhn on Detecting Circulating Tumor Cells". Xconomy. Wikipedia revision 1367626331, retrieved 2026-11-19
  3. ^ Zeliadt, Nicholette (April 1, 2014). "Capturing Cancer Cells on the Move: Three approaches for isolating and characterizing rare tumor cells circulating in the bloodstream Cancer Treatment from Just a Blood Sample". The Scientist. Wikipedia revision 1367626331, retrieved 2026-11-19
  4. ^ Gravitz, Lauren (February 21, 2014). "Personalized Cancer Treatment from Just a Blood Sample". Discover Magazine. Wikipedia revision 1367626331, retrieved 2026-11-19
  5. ^ Fikes, Bradley J. (July 30, 2014). "Epic Sciences raises $30 million". San Diego Union Tribune. Wikipedia revision 1367626331, retrieved 2026-11-19
  6. ^ "Biopharma just can't get enough of Epic Sciences - MedCity News". medcitynews.com. Retrieved 2017-04-28. Wikipedia revision 1367626331, retrieved 2026-11-19
edit edit source

Text derived from https://en.wikipedia.org/w/index.php?oldid=1367626331 under CC BY-SA 4.0; modifications have been made.

References

  1. ↩Wikipedia “Epic Sciences” revision 1367626331 · retrieved 2026-10-20 date of foundation (×1) · confidence 0.95 revision URL